Healthcare distributors that handle controlled substances and list 1 chemicals are subject to DEA and state requirements under state and federal Controlled Substances Acts. These requirements are usually aimed at preventing diversion and other criminal activities.

denotes HDMA members-only content. Join today.

Drug Enforcement Administration (DEA)

• National Prescription Drug Take-Back Day - Saturday, April 28, 2012 from 10am-2pm (Local Time)
• Joint Comments to DEA on Registration Fee Proposed Rule - September 8, 2011
• HDMA Comments to DEA on Registration Fee Proposed Rule - September 8, 2011
• HDMA Comments to DOJ on Retrospectice Review under Executive Order 13563 - July 12, 2011
• HDMA Comments on OMB's Information Collection on Reports of Suspicious Orders or Theft/Loss of Listed Chemical/Machines - June 22, 2011
• DEA Announcement of Media Roundtable on Synthetic Drugs - February 11, 2011
• HDMA Comments on DEA's Take Back Public Meeting - January 11, 2011
• HDMA Comments on DEA's Proposal to Place Propofol into Schedule IV - December 21, 2010
• DEA National Prescription Drug Take-Back Day - September 25, 2010
  Government, community, public health and law enforcement partners will be collecting potentially dangerous expired, unused, and unwanted prescription drugs for destruction at over 2700 sites nationwide on Saturday, September 25th. Click here to find a participating site: http://www.deadiversion.usdoj.gov/takeback/
• HDMA Comments on DEA's Proposed Rule to Place Carisoprodol into Schedule IV - December 17, 2009
• Cover Letter to HDMA Comments to FDA on the REMS for Certain Opioids - June 30, 2009
• HDMA comments on the FDA REMS for Certain Opioids - June 30, 2009
• HDMA Comments on DEA's Interim Final Rule Implementing the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 - June 5, 2009
• HDMA Comments to DEA on Pharmaceutical Take-Back Programs - March 23, 2009
  • Read the Related Comments to EPA on Pharmaceutical Waste Disposal - February 27, 2009
    
    
• HDMA Industry Compliance Guidelines - November 13, 2008
• DEA Letter on HDMA Industry Compliance Guidelines: Reporting Suspicious Orders
  and Preventing Diversion of Controlled Substances - November 13, 2008
• DEA Letter on Form 106 - October 27, 2008
• DEA Letter on Registration Requirements for Handlers of Iodine - April 29, 2008
• HDMA Comments on the Notice of Proposed Rulemaking Regarding DEA Form 222 - Feb. 8, 2008
• Cover letter to HDMA Comments on DEA Self-Certification Proposed Rule- Nov. 26, 2007
• Attachment: HDMA Comments on DEA Self-Certification Proposed Rule- Nov. 26, 2007
• DEA Letter on Import and Production Quotas rule - July 11, 2007
• DEA Letter on Regulation of Iodine - July 2, 2007
• DEA Letter on Theft of Hydrocodone Combination Products - June 22, 2007
• DEA Letter on LIst I and List II Chemical Importation/Exportation - April 9, 2007

Related Activities

• HDMA Final Comments Letter to DEA on the Proposed Rule on Chemical Mixtures Containing Listed Forms of Phosphorus and Change in Application Process - August 18, 2010
• HDMA Comment Letter to DEA on GBL - January 12, 2009
• HDMA Comments to FDA Regarding International Drug Scheduling of Dextromethorphan - October 20, 2008

Click here for more information on the Controlled Substance Ordering System.

Contacts
Anita Ducca
Vice President, Regulatory Affairs
703-885-0240
aducca@hdmanet.org

John Howells
Senior Director, Industry Relations
703-885-0277
jhowells@hdmanet.org

Dan Bellingham
Senior Director, State Government Affairs
703-885-0236
dbellingham@hdmanet.org